卡朋特科技(CRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRS 卡朋特科技

交易中 12-16 14:43:19 EST

320.30

-3.32

-1.03%

最高325.11	最低317.37	成交量51.50万
今开321.18	昨收323.62	日振幅2.39%
总市值159.57亿	流通市值155.34亿	总股本4,982万
成交额1.65亿	换手率1.06%	流通股本4,850万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRS","market":"US","secType":"STK","nameCN":"卡朋特科技","latestPrice":320.3,"timestamp":1765914196987,"preClose":323.62,"halted":0,"volume":514999,"delay":0,"floatShares":48497746,"shares":49818822,"eps":8.177718,"marketStatus":"交易中","change":-3.32,"latestTime":"12-16 14:43:19 EST","open":321.18,"high":325.105,"low":317.3692,"amount":165401044.3323,"amplitude":0.023904,"askPrice":320.8,"askSize":25,"bidPrice":319.87,"bidSize":79,"shortable":3,"etf":0,"ttmEps":8.177718,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":323.62,"dividendRate":0.002498,"preHourTrading":{"tag":"盘前","latestPrice":321.72,"preClose":323.62,"latestTime":"09:26 EST","volume":54,"amount":17416.27062,"timestamp":1765895164373},"postHourTrading":{"tag":"盘后","latestPrice":323.62,"preClose":323.62,"latestTime":"19:23 EST","volume":199736,"amount":64638611,"timestamp":1765844603465},"volumeRatio":0.465674,"impliedVol":0.4348,"impliedVolPercentile":0.184},"requestUrl":"/m/hq/s/CRS/tweets","defaultTab":"tweets","newsList":[{"id":"2590394122","title":"新股前瞻|布局TCE肿瘤疗法千亿蓝海，时迈药业能否博得市场青睐？","url":"https://stock-news.laohu8.com/highlight/detail?id=2590394122","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590394122?lang=zh_cn&edition=full","pubTime":"2025-12-09 13:05","pubTimestamp":1765256702,"startTime":"0","endTime":"0","summary":"近日，又一创新药企正式向港交所提交上市申请。在此背景下，作为一家专注于实体瘤TCE疗法、且具备多款全球前列临床管线的企业，时迈药业的上市进程亦自然备受瞩目。布局TCE疗法 四款创新药物处于临床阶段智通财经APP了解到，时迈药业目前仍处于临床研发阶段，并无产品商业化。根据时迈药业招股书披露，当前仅有两款用于实体瘤的TCE药物获得全球批准，市场存在大量空白，这为具备相关布局能力的创新药企提供了结构性机遇。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379203.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B66KJ199.SGD","LU0210528500.USD","BK4585","LU0963586101.USD","L","BK4187","BK4588","LU0053666078.USD","IE00B7SZL793.SGD","LU2065731478.USD","BK4006","BK4080","ORR","BK4231","IE0031619046.USD","IE00B19Z4B17.USD","LU2487616109.SGD","ADC","BK4107","CRS"],"gpt_icon":0},{"id":"2590451393","title":"吉利德Anito-cel 神经毒性低，2年多发性骨髓瘤生存率高 | ASH25","url":"https://stock-news.laohu8.com/highlight/detail?id=2590451393","media":"Minhua笔记","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590451393?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:58","pubTimestamp":1765166299,"startTime":"0","endTime":"0","summary":"在ASH 2025年会上，吉利德旗下Kite Pharma公布Anito-cel在iMMagine-1 II期试验中的更新数据，该靶向BCMA的CAR-T疗法在复发/难治性多发性骨髓瘤患者中显示96% ORR、74% sCR/CR率、95% MRD阴性率，中位随访15.9个月，缓解持续。III期iMMagine-3试验正在招募中，该研究将Anito-cel与标准治疗比较，预计2026年获得数据；该药物获FDA快速通道、孤儿药和RMAT资格。ICANS 发生率为 8%，其中 1 例为 3 级；其余均为 2 级或更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CR","BK4187","IE00B3T34201.USD","BK4588","LU1571399168.USD","BK4532","IE00B66KJ199.SGD","LU1585245621.USD","IE00B19Z3581.USD","BK4566","IE00B19Z4B17.USD","ORR","BK4097","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1674673428.USD","BK4195","CRS","IE00BZ1G4Q59.USD","KOL","LU0882574055.USD","LU0109394709.USD","GILD","IE0002270589.USD","LU1778281490.HKD","LU0889565916.HKD","LU1674673691.USD","SG9999015986.USD","OS","IE00B7SZL793.SGD","SG9999015978.USD","BK4568","LU1839511570.USD","BK4585","IE00BKVL7J92.USD","SG9999015952.SGD","BK4550","LU0234570918.USD","PFS","LU0823416689.USD","ASH","LU1066051498.USD","LU1430594728.SGD","SG9999015945.SGD","LU0289739699.SGD","BK4578","BK4139","BK4109"],"gpt_icon":0},{"id":"1125690238","title":"卡朋特科技公司：11月20日与他人签订信贷协议的修订和重述","url":"https://stock-news.laohu8.com/highlight/detail?id=1125690238","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125690238?lang=zh_cn&edition=full","pubTime":"2025-11-21 05:47","pubTimestamp":1763675228,"startTime":"0","endTime":"0","summary":"卡朋特科技公司：11月20日与他人签订信贷协议的修订和重述","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","IE00B7SZL793.SGD","IE0031619046.USD","CRS","BK4006","LU0963586101.USD","LU2065731478.USD","IE00B66KJ199.SGD","BK4187"],"gpt_icon":0},{"id":"1101983614","title":"卡朋特科技宣布完成7亿美元的5.625%2034年到期高级票据私人发行及信贷协议修订","url":"https://stock-news.laohu8.com/highlight/detail?id=1101983614","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101983614?lang=zh_cn&edition=full","pubTime":"2025-11-21 05:16","pubTimestamp":1763673386,"startTime":"0","endTime":"0","summary":"卡朋特科技宣布完成7亿美元的5.625%2034年到期高级票据的私人发行，并修订了信贷协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","CRS","BK4006","LU0963586101.USD","IE00B19Z4B17.USD","IE0031619046.USD","IE00B7SZL793.SGD","BK4187","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2585197632","title":"卡朋特科技盘中异动 快速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585197632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585197632?lang=zh_cn&edition=full","pubTime":"2025-11-21 00:45","pubTimestamp":1763657141,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日00时45分，卡朋特科技股票出现波动，股价急速下挫5.03%。截至发稿，该股报307.84美元/股，成交量22.4678万股，换手率0.45%，振幅7.31%。卡朋特科技股票所在的金属制品行业中，整体跌幅为2.66%。其相关个股中，Mayville Engineering Company, Inc.、Insteel工业、Proto Labs, Inc.涨幅较大，Safe & Green Holdings Corp.、Mayville Engineering Company, Inc.、卡朋特科技较为活跃，换手率分别为1221.79%、0.54%、0.46%，振幅较大的相关个股有Safe & Green Holdings Corp.、铭腾国际、卡朋特科技，振幅分别为62.77%、9.32%、7.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511210045429775f1af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511210045429775f1af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","BK4187","IE00B66KJ199.SGD","CRS","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4006","LU0963586101.USD","IE0031619046.USD"],"gpt_icon":0},{"id":"1169662689","title":"卡朋特科技宣布7亿美元5.625%高级票据私募发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1169662689","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169662689?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:20","pubTimestamp":1763572820,"startTime":"0","endTime":"0","summary":"11月11日 - 卡朋特科技公司宣布其7亿美元5.625%高级票据私募发行的定价，该票据将于2034年到期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","CRS","IE00B66KJ199.SGD","BK4006","IE0031619046.USD","BK4187","LU0963586101.USD","IE00B19Z4B17.USD","LU2065731478.USD"],"gpt_icon":0},{"id":"2584323984","title":"国产三抗新药首次公布临床结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2584323984","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584323984?lang=zh_cn&edition=full","pubTime":"2025-11-17 19:28","pubTimestamp":1763378888,"startTime":"0","endTime":"0","summary":"2025 年美国血液学会年会将于当地时间 12 月 6 日到 12 月 9 日在美国佛罗里达州奥兰多市召开，目前常规摘要已经公布。齐鲁制药将在本次会议上首次公布下一代GPRC5D×BCMA×CD3三抗 QLS4131在复发或难治性多发性骨髓瘤患者中首次人体试验的初步研究结果。这是一项评价QLS4131 在 RRMM 患者中的安全性、耐受性、药代动力学、免疫原性以及初步有效性的 I 期临床研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223327a4a7ede6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223327a4a7ede6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765646.SGD","LU0098860793.USD","LU0203345920.USD","LU0792757196.USD","IE00B19Z4B17.USD","IE00BGHQF631.EUR","LU1074936037.SGD","LU2129689605.HKD","BK4019","KG","JNJ","BK4121","TRAE","LU0889566641.SGD","LU0203347892.USD","IE00BSNM7G36.USD","PR","LU0963586101.USD","LU1674673691.USD","BK4585","IE00BLSP4452.SGD","LU2129689431.USD","BK4567","IE00BJJMRZ35.SGD","BK4533","ASH","BK4581","LU1914381329.SGD","SG9999001440.SGD","BK4532","IE00BFTCPJ56.SGD","IE00BVYPNV92.GBP","BK4534","LU0122379950.USD","LU2413666699.HKD","BK4007","IE00B7SZL793.SGD","LU0070217475.USD","LU0882574055.USD","LU1732800096.USD","LU1244550577.SGD","IE00B7SZLL34.SGD","LU1066053197.SGD","IE0034235303.USD","LU2592432038.USD","CRS","BK4187","IE00BFXG1179.USD","LU2129689514.USD","MTD"],"gpt_icon":0},{"id":"2582366645","title":"医药领域，这些潜力赛道即将爆发！","url":"https://stock-news.laohu8.com/highlight/detail?id=2582366645","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582366645?lang=zh_cn&edition=full","pubTime":"2025-11-11 19:13","pubTimestamp":1762859617,"startTime":"0","endTime":"0","summary":"2025年，默克宣布与加拿大AI制药公司Variational AI达成协议，潜在交易总价值达3.49亿美元，默克将利用其AI药物发现平台设计和优化针对两个未公开靶点的小分子候选药物。礼来的Orforglipron在全球口服小分子中进展最快，预计今年年底递交上市申请（图3），国内企业如恒瑞医药、华东医药、闻泰科技等也在该领域积极布局，部分管线已进入临床中后期，展现出较强的出海潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111200654a6f1f725&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111200654a6f1f725&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0031619046.USD","CRS","IE00B7SZL793.SGD","LU0154236417.USD","01276","BK4585","09887","BK4532","BK4187","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00B19Z4B17.USD","IE00B66KJ199.SGD","LU1093756168.USD","BK4006","LU0963586101.USD","NVO","LU2065731478.USD","BK4007","BK4588","BK4599","06998","LU1093756325.SGD","02105"],"gpt_icon":1},{"id":"1192515076","title":"卡朋特科技宣布拟发行7亿美元的2034年到期高级票据私募","url":"https://stock-news.laohu8.com/highlight/detail?id=1192515076","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192515076?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:37","pubTimestamp":1762778233,"startTime":"0","endTime":"0","summary":"卡朋特科技宣布拟发行7亿美元的2034年到期高级票据私募","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","CRS","BK4006","LU0963586101.USD","IE00B19Z4B17.USD","IE0031619046.USD","IE00B7SZL793.SGD","BK4187","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"1114062329","title":"异动解读 | 卡朋特科技股价盘中大涨5.07%，多家券商上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1114062329","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114062329?lang=zh_cn&edition=full","pubTime":"2025-10-25 02:34","pubTimestamp":1761330870,"startTime":"0","endTime":"0","summary":"周五盘中，卡朋特科技股价大涨5.07%。消息面上，多家券商上调了该公司的目标股价，提振了投资者信心。德意志银行分析师将卡朋特科技的目标价从375美元大幅上调至425美元，上调幅度达13.3%。同时，TD Cowen也将目标价从305美元上调至340美元，上调幅度为11.5%。卡朋特科技是一家专业生产和销售高性能特种合金的公司。投资者对此反应积极，推动股价强劲上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRS"],"gpt_icon":0},{"id":"1155835688","title":"异动解读 | 卡朋特科技发布乐观财务预期，股价盘中大涨7.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155835688","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155835688?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:33","pubTimestamp":1761226420,"startTime":"0","endTime":"0","summary":"卡朋特科技今日盘中大涨7.13%，引起了投资者的广泛关注。该公司股价的强劲表现与其最新发布的乐观财务预期密切相关。根据公司发布的多项财务预期，卡朋特科技展现出强劲的增长势头。公司预计2026财年第二季度运营收入将在1.52亿至1.56亿美元之间，2026财年全年运营收入有望达到6.6亿至7亿美元。这些积极的财务预期无疑增强了市场对卡朋特科技未来成长性的信心。投资者对公司的长期发展前景持乐观态度，推动了股价的大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRS"],"gpt_icon":0},{"id":"1123443632","title":"卡朋特科技：预计2026财年运营收入将在6.6亿至7亿美元之间","url":"https://stock-news.laohu8.com/highlight/detail?id=1123443632","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123443632?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:09","pubTimestamp":1761221358,"startTime":"0","endTime":"0","summary":"卡朋特科技：预计2026财年运营收入将在6.6亿至7亿美元之间","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","BK4187","IE00B66KJ199.SGD","CRS","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4006","LU0963586101.USD","IE0031619046.USD"],"gpt_icon":0},{"id":"1116242029","title":"卡朋特科技：2026财年第二季度预计运营收入在1.52亿至1.56亿之间","url":"https://stock-news.laohu8.com/highlight/detail?id=1116242029","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116242029?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:09","pubTimestamp":1761221357,"startTime":"0","endTime":"0","summary":"卡朋特科技：2026财年第二季度预计运营收入在1.52亿至1.56亿之间","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","BK4187","IE00B66KJ199.SGD","CRS","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4006","LU0963586101.USD","IE0031619046.USD"],"gpt_icon":0},{"id":"1170608064","title":"卡朋特科技公司承诺在2027财年实现7.65亿至8亿美元的运营收入目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1170608064","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170608064?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:09","pubTimestamp":1761221355,"startTime":"0","endTime":"0","summary":"卡朋特科技公司承诺在2027财年实现7.65亿至8亿美元的运营收入目标","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0963586101.USD","CRS","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4187","BK4006","LU2065731478.USD","IE0031619046.USD","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"1142998561","title":"异动解读 | 卡朋特科技盘中大跌6.95%，季度营收不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1142998561","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142998561?lang=zh_cn&edition=full","pubTime":"2025-07-31 22:15","pubTimestamp":1753971336,"startTime":"0","endTime":"0","summary":"周四盘中，特种金属制造商卡朋特科技股价大幅下跌6.95%，引发市场关注。这一跌幅可能与公司最新发布的季度财报有关。根据公司公布的截至6月30日的季度业绩报告，卡朋特科技调整后每股收益为2.21美元，高于分析师预期的2.07美元，也超过去年同期的1.82美元。尽管卡朋特科技的每股收益表现优异，但营收下滑和未达预期可能引发了投资者对公司增长前景的担忧，导致股价出现大幅下跌。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRS"],"gpt_icon":0},{"id":"2555343839","title":"卡朋特科技盘中异动 大幅跳水5.40%报268.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555343839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555343839?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:36","pubTimestamp":1753969002,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时36分，卡朋特科技股票出现异动，股价大幅跳水5.40%。截至发稿，该股报268.30美元/股，成交量5.1143万股，换手率0.10%，振幅5.49%。卡朋特科技股票所在的金属制品行业中，整体跌幅为3.53%。其相关个股中，Proto Labs, Inc.、铭腾国际、Esab Corporation涨幅较大，Safe & Green Holdings Corp.、阿勒格尼技术、铭腾国际较为活跃，换手率分别为1.82%、0.28%、0.10%，振幅较大的相关个股有铭腾国际、卡朋特科技、阿勒格尼技术，振幅分别为6.45%、5.49%、5.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213642972a4ec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213642972a4ec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","CRS","BK4006","LU0963586101.USD","IE00B19Z4B17.USD","IE0031619046.USD","IE00B7SZL793.SGD","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2555034275","title":"CRS补税风暴来临！你持有的港股、美股需要缴税吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555034275","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555034275?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:08","pubTimestamp":1753780088,"startTime":"0","endTime":"0","summary":"2025年6月30日，一年一度的个人所得税汇算清缴申报期正式关闭，但许多持有海外资产的纳税人发现，税务部门的监管并未随之松懈，短信提醒、电话问询、App弹窗通知接踵而至，部分地方税务局更是在官网公示《税务事项通知书》，要求当事人限期进行纳税申报。境外所得申报缴税正在成为税务监管的“风暴眼”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://finance.eastmoney.com/news/1353,202507293470355673.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1353,202507293470355673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["HSCEI","IE00B19Z4B17.USD","IE00B7SZL793.SGD","IE0031619046.USD","HSTECH","CRS","BK4006","LU0963586101.USD","LU2065731478.USD","BK4614","07226","YANG","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2552107687","title":"巨头加码，三抗成为“新风口”","url":"https://stock-news.laohu8.com/highlight/detail?id=2552107687","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552107687?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:03","pubTimestamp":1752739384,"startTime":"0","endTime":"0","summary":"ISB 2001在组合中加入CD38，增强对BCMA低表达肿瘤细胞的结合能力，并通过下调抗原表达来阻止癌症产生耐药性，有望成为新一代治疗多发性骨髓瘤的药物。02三抗正在成为新风口单克隆抗体药物因其特异性强、靶向性高和毒副作用小等特点，已在肿瘤、自身性免疫疾病等领域广泛应用。目前，全球已有多款双特异性抗体药物获批上市，适应证主要集中在肿瘤领域。在国内药企中，三特异性抗体同样受到追崇。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717161118a6af3e8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717161118a6af3e8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4006","SLE","PFE","MRK","BK4161","IE00B66KJ199.SGD","CR","AZN","LU2065731478.USD","ORR","BK4077","IGI","IE0031619046.USD","JNJ","CRS","IE00B7SZL793.SGD","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2551974502","title":"三抗市场再起波澜！艾伯维19.25亿美元引进一款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2551974502","media":"制药网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551974502?lang=zh_cn&edition=full","pubTime":"2025-07-14 14:10","pubTimestamp":1752473456,"startTime":"0","endTime":"0","summary":"IGI则将获得7亿美元的预付款，同时还有资格获得高达12.25亿美元的开发、监管和商业化里程碑付款，外加基于净销售额的两位数分层特许权使用费，总交易金额最高可达19.25亿美元，足以彰显双方对这款药物的高度信心。根据协议，艾伯维将支付给先声再明一定的预付款，以及最高10.55亿美元的选择性权益付款和里程碑付款，外加大中华区以外地区的销售分成。短短半年内，艾伯维在三抗领域连续出手，足以看出其对这一领域的重视和布局的决心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507141413469541b2c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507141413469541b2c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0256863811.USD","LU0795875169.SGD","LU0882574055.USD","LU1496350502.SGD","LU1093756325.SGD","LU1934455194.USD","BK4588","IE00B19Z4B17.USD","IE00BVYPNW00.USD","LU1989771016.USD","LU0203347892.USD","LU0234570918.USD","LU2065731478.USD","LU0820561818.USD","LU1291159041.SGD","LU1989772840.SGD","PK","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU0708994859.HKD","TRAE","BK4534","ABBV","LU2112291526.USD","IE00B7SZL793.SGD","LU1244550221.USD","LU0320765646.SGD","LU2347655156.SGD","CRS","SG9999015986.USD","LU1430594728.SGD","LU2133065610.SGD","LU0417517546.SGD","BK4550","LU1496350171.SGD","PD","LU2468319806.SGD","LU2129689514.USD","LU1057294990.SGD","LU1244550577.SGD","LU0158827948.USD","LU1267930490.SGD","LU1162221912.USD","LU0738911758.USD","LU1244550494.USD","ORR","LU0965509283.SGD","LU2237443549.SGD","LU2237443895.HKD","LU2237443978.SGD"],"gpt_icon":0},{"id":"2551912315","title":"19.25亿，艾伯维引进CD3/BCMA/CD38管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2551912315","media":"药渡","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551912315?lang=zh_cn&edition=full","pubTime":"2025-07-13 07:30","pubTimestamp":1752363052,"startTime":"0","endTime":"0","summary":"ISB 2001 是同类首创的三特异性 T 细胞接合剂，靶向骨髓瘤细胞上的 BCMA 和 CD38 以及 T 细胞上的 CD3，目前正处于复发/难治性多发性骨髓瘤的 I 期临床研究。在25 名对抗 CD38 疗法有耐药性的患者中，ORR 为 72%，CR/sCR 率为 24%。在15 名接受过 BCMA 靶向治疗的患者中，ORR 为 73%，CR/sCR 率为 27%。CD3/BCMA/CD38三抗业界做的人不多，其实2020年有文章初步显示，做三抗具有一定可行性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250713073357a447180c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250713073357a447180c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1267930573.SGD","LU2347655156.SGD","LU1267930490.SGD","LU0889566641.SGD","LU2430703251.USD","RR","BK4592","IE00B4R5TH58.HKD","LU1914381329.SGD","LU2087621335.USD","LU0211327993.USD","IE00BVYPNW00.USD","ABBV","LU1093756325.SGD","LU0256863811.USD","LU0320765646.SGD","LU2505996681.GBP","IE00B2B36J28.USD","BK4568","LU0820561909.HKD","LU0965508806.USD","LU1934455277.USD","IGI","LU0456855351.SGD","IE00BJJMRZ35.SGD","LU1894683264.USD","LU0689472784.USD","LU2602419157.SGD","IE00B3PB1722.GBP","BK4566","IE00BDGV0183.EUR","JNJ","IE00B66KJ199.SGD","IE0004445239.USD","CRS","LU0792757196.USD","SG9999015945.SGD","LU2089284900.SGD","LU1032466523.USD","IE00B7SZL793.SGD","LU1066051225.USD","LU2237443465.HKD","LU0708994859.HKD","LU0114720955.EUR","LU0965509283.SGD","LU1496350502.SGD","LU1674673691.USD","LU1244550221.USD","BK4007","LU0861579265.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carpentertechnology.com","stockEarnings":[{"period":"1week","weight":0.0498},{"period":"1month","weight":-0.0208},{"period":"3month","weight":0.3418},{"period":"6month","weight":0.2895},{"period":"1year","weight":0.8589},{"period":"ytd","weight":0.9069}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Carpenter Technology Corporation成立于1889年，是特拉华州的一家公司。该公司从事特种金属的制造和分销。该公司是优质特种合金的生产商和分销商，包括钛合金、粉末金属、不锈钢、合金钢和工具钢。在航空航天、国防、医疗、运输、能源、工业和消费市场的关键应用领域，该公司是公认的高性能特种合金材料和工艺解决方案的领导者。该公司已经发展成为优质特种合金的先驱，包括钛、镍和钴，以及专门为增材制造工艺和软磁应用设计的合金。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.007065},{"month":2,"riseRate":0.644444,"avgChangeRate":0.022439},{"month":3,"riseRate":0.533333,"avgChangeRate":0.000821},{"month":4,"riseRate":0.565217,"avgChangeRate":0.044931},{"month":5,"riseRate":0.543478,"avgChangeRate":0.024379},{"month":6,"riseRate":0.521739,"avgChangeRate":-0.000496},{"month":7,"riseRate":0.5,"avgChangeRate":0.022964},{"month":8,"riseRate":0.456522,"avgChangeRate":-0.007895},{"month":9,"riseRate":0.608696,"avgChangeRate":-0.003285},{"month":10,"riseRate":0.347826,"avgChangeRate":-0.015075},{"month":11,"riseRate":0.717391,"avgChangeRate":0.060126},{"month":12,"riseRate":0.630435,"avgChangeRate":0.016772}],"exchange":"NYSE","name":"卡朋特科技","nameEN":"Carpenter Technology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"卡朋特科技(CRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供卡朋特科技(CRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"卡朋特科技,CRS,卡朋特科技股票,卡朋特科技股票老虎,卡朋特科技股票老虎国际,卡朋特科技行情,卡朋特科技股票行情,卡朋特科技股价,卡朋特科技股市,卡朋特科技股票价格,卡朋特科技股票交易,卡朋特科技股票购买,卡朋特科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"卡朋特科技(CRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供卡朋特科技(CRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}